Skip to main content
CABA
NASDAQ Life Sciences

Cabaletta Extends Cash Runway Into 1Q28 With $299.4M, Starts Second Registrational Study

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.48
Mkt Cap
$240.755M
52W Low
$1.32
52W High
$4.23
52W Position info
12% above low
Off High info
65% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

CABA is trading near its 52-week low of $1.32 (12% above the low).

Summary

Cabaletta ended September with $299.4M in cash, up from $133.6M at year-end, and now says that funds the operating plan into 1Q28 — a meaningful extension for a company that carried a going concern warning in its Q2 10-Q. The quarter itself was a wider loss, $53.1M versus $44.9M a year ago, with R&D at $47.1M, though the net loss came in slightly better than analyst expectations. The bigger news is clinical: the RESET-Myositis registrational topline is now guided to 2H27 with a BLA in 1Q28, and the company initiated its second registrational cohort, RESET-SSc, in systemic sclerosis-ILD patients. Management said enrollment in the adult myositis study picked up in recent weeks after a slow 3Q26 that it attributes to patient and physician caution following safety events reported by others in the field. One-year dermatomyositis and up-to-two-year lupus nephritis durability data, plus updated RESET safety data, are due at ACR Convergence, with the oral presentation on November 8 and posters on November 9.

At the time of this announcement, CABA was trading at $1.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $240.8M. The 52-week trading range was $1.32 to $4.23. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CABA - Latest Insights

CABA
Nov 05, 2026, 7:34 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.48
Real-time Price: $1.27 info
Change: -$0.2103 (-14%) info
Market Cap: $217.018M info
CABA
Sep 14, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.77
Real-time Price: $1.27 info
Change: -$1.50 (-54%) info
Market Cap: $217.018M info
CABA
Aug 13, 2026, 7:34 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.82
Real-time Price: $1.27 info
Change: -$1.55 (-55%) info
Market Cap: $217.018M info
CABA
Aug 13, 2026, 7:32 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.82
Real-time Price: $1.27 info
Change: -$1.55 (-55%) info
Market Cap: $217.018M info
CABA
Aug 13, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.90
Real-time Price: $1.27 info
Change: -$1.63 (-56%) info
Market Cap: $217.018M info